Found 19 matching trials
A Study to Assess the Effect of RO4607381 in Patients With Relatively Low Levels of High Density Lipoprotein-Cholesterol (HDL-C)
PHASE2This 4 arm study will evaluate the efficacy and safety of RO4607381 when co...
Location
Multiple Locations
Safety and Efficacy Study of JTT-705 in Combination With Simvastatin 40 mg in Patients With Low High-Density Lipoprotein (HDL) Levels
PHASE2The purpose of this study is to evaluate safety of JTT-705 and to demonstra...
Location
Multiple Locations
A Study of the Metabolic Profile of Dalcetrapib in Healthy Volunteers
PHASE1This single center, open-label, non-randomized, one-treatment, one-period s...
Location
Multiple Locations
A Long Term Extension of Study NC19453 Evaluating Safety and Efficacy of RO4607381
PHASE2This 2 arm study will assess the long term safety and efficacy of RO4607381...
Location
Multiple Locations
A Study Assessing the Effect of RO4607381 on Vascular Function in Patients With Coronary Heart Disease (CHD) or CHD-Risk Equivalent Patients
PHASE2This study will assess the safety, tolerability and efficacy of RO4607381 i...
Location
Multiple Locations
Effect of Dalcetrapib in Patients With Confirmed Mild to Moderate COVID-19
PHASE2This study is a placebo-controlled, Phase 2a proof-of-concept clinical stud...
Location
Institut de Cardiologie de Montréal
Efficacy and Safety of JTT-705 300, 600 And 900mg in Comparison With Placebo in Patients With Type II Hyperlipidaemia
PHASE2To demonstrate the effect of JTT-705 doses from 300 mg to 900 mg on the ele...
Location
Amsterdam, Utrecht, Rotterdam, Nijmegen, Arnhem, Groningen, Dordrecht, Hoorn, Groningen
Real-world Studies of CDK4/6 Inhibitors
N/AA single-center, real-world study evaluated the clinical outcomes and safet...
Location
Tianjin Medical University Cancer Insititute and Hospital
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
PHASE3This is a placebo-controlled, randomized, double-blind, parallel group, pha...
Efficacy and Safety Study of JTT-705 in Combination With Pravastatin 40 mg in Patients With Type II Hyperlipidemia
PHASE2The purpose of this study is to evaluate the effect of two dose levels of J...
Location
Multiple Locations